معرفی
Julien Nicolas is a Researcher at Institut Galien, a multidisciplinary research entity affiliated with Université Paris-Saclay and CNRS. His work bridges chemistry, pharmacy, and medicine, focusing on polymer materials for drug delivery systems.
- Education: Graduated from École supérieure de chimie organique et minérale (ESCOM) in 2001; completed Ph.D. at Université Pierre et Marie Curie (now Sorbonne Université) on controlled free-radical polymerization.
Research Interests: Julien Nicolas specializes in developing biodegradable nanoparticles for targeted therapies (e.g., Alzheimer's disease, cancer) and prodrug nanoparticulate systems. His innovations aim to enhance drug stability, solubility, and subcutaneous administration.
Scientific Contributions:
- Developed polymer-protein bioconjugates during postdoctoral research at the University of Warwick (UK).
- Pioneered methods to grow polymers directly from active pharmaceutical ingredients, improving drug loading efficiency.
- Co-founded a startup to commercialize patented cancer therapy delivery systems.
Grants & Recognition: Awarded the Novacap Prize (2018) for therapeutic chemistry innovation and an European Research Council (ERC) grant to advance his research.
۰مقاله منتشرشده
